Silvia Costabile
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Hemostatic Aspects of Interactions Between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous Thromboembolism.
Journal: Seminars in thrombosis and hemostasis
Published: May 12, 2026
Tissue and circulating biomarkers in advanced melanoma patients receiving dabrafenib and trametinib.
Tissue and circulating biomarkers in advanced melanoma patients receiving dabrafenib and trametinib.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 26, 2026
High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Journal: Journal of translational medicine
Published: October 02, 2025
Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer.
Journal: ImmunoTargets and therapy
Published: September 16, 2025
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 29, 2025
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies.
Journal: Expert opinion on emerging drugs
Published: April 04, 2024
Correction: Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Journal: Oncology and therapy
Published: January 03, 2024
Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Journal: Oncology and therapy
Published: September 18, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026